Downregulation of BTG3 in non-small cell lung cancer

Biochemical and Biophysical Research Communications

Volumn 437, Issue 1, 2013, Pages 173-178

  Chen, Xiaobing ^a,b   Chen, Guoyong ^b   Cao, Xinguang ^a   Zhou, Yudong ^b   Yang, Tiejun ^a   Wei, Sidong ^b  

^a ZHENGZHOU UNIVERSITY   (China)

^b People's Hospital of Zhengzhou   (China)

Author keywords

BTG3; Isoforms; Lung cancer

Indexed keywords

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; AUTOPHAGY; BTG3 GENE; CANCER CELL CULTURE; CANCER GROWTH; CANCER TISSUE; CARCINOGENICITY; CELL CYCLE; CELL DIFFERENTIATION; COLONY FORMATION; CONTROLLED STUDY; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; LUNG SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION; TUMOR SUPPRESSOR GENE;

BTG3; ISOFORMS; LUNG CANCER;

ANIMALS; AUTOPHAGY; CARCINOMA, NON-SMALL-CELL LUNG; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MICE; MICE, NUDE; NEOPLASM METASTASIS; PROTEINS; RNA, MESSENGER;

MUS;

EID: 84880514855     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.06.062     Document Type: Article

References (16)

1. Koga T., Takeshita M., Yano T., Maehara Y., Sueishi K. CHFR hypermethylation and EGFR mutation are mutually exclusive and exhibit contrastive clinical backgrounds and outcomes in non-small cell lung cancer. Int. J. Cancer 2011, 128:1009-1017.
2. Hong K.M., Yang S.H., Chowdhuri S.R., Player A., Hames M., Fukuoka J., Meerzaman D., Dracheva T., Sun Z., Yang P., Jen J. Inactivation of LLC1 gene in nonsmall cell lung cancer. Int. J. Cancer 2007, 120:2353-2358.
3. Yoneda M., Suzuki T., Nakamura T., Ajima R., Yoshida Y., Kakuta S., Katsuko S., Iwakura Y., Shibutani M., Mitsumori K., Yokota J., Yamamoto T. Deficiency of antiproliferative family protein Ana correlates with development of lung adenocarcinoma. Cancer Sci. 2009, 100:225-232.
4. Cortes U., Moyret-Lalle C., Falette N., Duriez C., Ghissassi F.E., Barnas C., Morel A.P., Hainaut P., Magaud J.P., Puisieux A. BTG gene expression in the p53-dependent and -independent cellular response to DNA damage. Mol. Carcinog. 2000, 27:57-64.
5. Cheng Y.C., Lin T.Y., Shieh S.Y. Candidate tumor suppressor BTG3 maintains genomic stability by promoting Lys63-linked ubiquitination and activation of the checkpoint kinase CHK1. Proc. Natl. Acad. Sci. USA 2013, 110:5993-5998.
6. Majid S., Dar A.A., Ahmad A.E., Hirata H., Kawakami K., Shahryari V., Saini S., Tanaka Y., Dahiya A.V., Khatri G., Dahiya R. BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer. Carcinogenesis 2009, 30:662-670.
7. Ou Y.H., Chung P.H., Hsu F.F., Sun T.P., Chang W.Y., Shieh S.Y. The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1. EMBO J. 2007, 26:3968-3980.
8. Yamamoto N., Uzawa K., Yakushiji T., Shibahara T., Noma H., Tanzawa H. Analysis of the ANA gene as a candidate for the chromosome 21q oral cancer susceptibility locus. Br. J. Cancer 2001, 84:754-759.
9. Lin T.Y., Cheng Y.C., Yang H.C., Lin W.C., Wang C.C., Lai P.L., Shieh S.Y. Loss of the candidate tumor suppressor BTG3 triggers acute cellular senescence via the ERK-JMJD3-p16(INK4a) signaling axis. Oncogene 2011, 31:3287-3297.
10. Putnik M., Zhao C., Gustafsson J.A., Dahlman-Wright K. Global identification of genes regulated by estrogen signaling and demethylation in MCF-7 breast cancer cells. Biochem. Biophys. Res. Commun. 2012, 426:26-32.
11. Majid S., Dar A.A., Shahryari V., Hirata H., Ahmad A., Saini S., Tanaka Y., Dahiya A.V., Dahiya R. Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene B-Cell translocation gene 3 in prostate cancer. Cancer 2010, 116:66-76.
12. Yu J., Zhang Y., Qi Z., Kurtycz D., Vacano G., Patterson D. Methylation-mediated downregulation of the B-cell translocation gene 3 (BTG3) in breast cancer cells. Gene Expr. 2008, 14:173-182.
13. Han W., Pan H., Chen Y., Sun J., Wang Y., Li J., Ge W., Feng L., Lin X., Wang X., Wang X., Jin H. EGFR tyrosine kinase inhibitors activate autophagy as a cytoprotective response in human lung cancer cells. PLoS ONE 2011, 6:e18691.
14. Sui X., Jin L., Huang X., Geng S., He C., Hu X. P53 signaling and autophagy in cancer: a revolutionary strategy could be developed for cancer treatment. Autophagy 2011, 7:565-571.
15. Cho Y.Y., Kim D.J., Lee H.S., Jeong C.H., Cho E.J., Kim M.O., Byun S., Lee K.Y., Yao K., Carper A., Langfald A., Bode A.M., Dong Z. Autophagy and cellular senescence mediated by Sox2 suppress malignancy of cancer cells. PLoS ONE 2013, 8:e57172.
16. Young A.R., Narita M., Ferreira M., Kirschner K., Sadaie M., Darot J.F., Tavare S., Arakawa S., Shimizu S., Watt F.M., Narita M. Autophagy mediates the mitotic senescence transition. Genes Dev. 2009, 23:798-803.